InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
3
T+90 hit rate
29%
T+90 mean return
-2.9%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by BOYER ANDREW S, Vice-Président Exécutif. Director active across 1 company, notably Amneal Pharmaceuticals, Inc.. Cumulatively, 20 disclosures have been published. Breakdown: 0 buy · 3 sells. Total volume traded: €1.3m. Activity tracked since 3 March 2023. The latest transaction was filed on 5 March 2025 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations20 total
125,000 shares@ US$8.8977.4% of flowClass A Common StockSEC:0001628280-25-011310:0
39,251 sharesClass A Common StockSEC:0001628280-25-010718:0
31,371 sharesClass A Common StockSEC:0001628280-25-010118:0
22,486 shares@ US$7.8111.8% of flowClass A Common StockSEC:0001628280-24-037559:0
31,371 sharesClass A Common StockSEC:0001628280-24-008951:0
31,663 sharesClass A Common StockSEC:0001628280-24-007998:0
29,302 shares@ US$4.12678.2% of flowClass A Common StockSEC:0001209191-23-045846:0
23,095 sharesClass A Common StockSEC:0001209191-23-041087:0
39,251 sharesClass A Common StockSEC:0001209191-23-016929:0
19,685 shares@ US$1.922.6% of flowClass A Common StockSEC:0001209191-23-016929:1
12,346 sharesClass A Common StockSEC:0001209191-23-015521:0
31,662 sharesClass A Common StockSEC:0001209191-23-014118:0
23,094 sharesClass A Common StockSEC:0001209191-22-040624:0
16,656 sharesClass A Common StockSEC:0001209191-22-028154:0
12,346 sharesClass A Common StockSEC:0001209191-22-016047:0
31,662 sharesClass A Common StockSEC:0001209191-22-014133:0
23,095 sharesClass A Common StockSEC:0001209191-21-044367:0
23,095 sharesClass A Common StockSEC:0001209191-21-044367
16,655 sharesClass A Common StockSEC:0001209191-21-031565:0
16,655 sharesClass A Common StockSEC:0001209191-21-031565
20 of 20 declarations
About BOYER ANDREW S
Andrew S. Boyer is the Executive Vice President at Amneal Pharmaceuticals, Inc. In this role, he is responsible for the strategic direction and management of the company's operations. Boyer brings significant expertise in the pharmaceutical sector, contributing to growth and innovation.
